Peripheral Vascular Interventional Device Market Growing at CAGR — 2026 Report

Peripheral Vascular Interventional Device by Application (Hospital, Research Institutions), by Types (Bracket, Catheter, Guide Wire), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 101

Forecast Period: 2026 - 2033

Market Size: $5200 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 101

Forecast Period: 2026 - 2033

Market Size: $5200 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Peripheral Vascular Interventional Device Market Overview

The Peripheral Vascular Interventional Device market comprises minimally invasive tools—such as balloon catheters, stent grafts, and atherectomy systems—used to diagnose and treat peripheral arterial disease (PAD) and related vascular conditions. This market is pivotal for reducing limb‑loss rates and improving quality of life across aging populations. According to recent industry reports, the Peripheral Vascular Interventional Device market size reached approximately $9.5 billion in 2025, and analysts project a robust growth outlook driven by technological innovation and expanding reimbursement frameworks. The market forecast anticipates a compound annual growth rate (CAGR) of 6.5% from 2026 to 2033, underscoring a significant industry expansion across both mature and emerging economies.

Loading chart…

Key forces shaping the market include: (1) technological shifts, notably drug‑coated balloons and bioresorbable scaffolds that boost procedural efficacy; (2) regulatory momentum, with accelerated approvals and favorable reimbursement policies in the U.S., EU, and Japan; and (3) demographic pressure, as the global prevalence of PAD is projected to rise by 15% over the next decade. North America remains the largest market, reflecting advanced healthcare infrastructure and high adoption rates, while the Asia‑Pacific region is emerging as the fastest‑growing market, propelled by expanding middle‑class populations, increasing hospital capacity, and supportive government initiatives. These dynamics collectively position the Peripheral Vascular Interventional Device market for sustained growth and strategic opportunity.

Report Overview

Report Attribute	Details
Market size value in 2025	5.20 billion
Revenue forecast in 2033	13.15 billion
Growth rate	CAGR of 12.3% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Medtronic; Shockwave Medical; Boston Scientific; Becton Dickinson; Abbott; Terumo Corporation; Nipro Corporation; Asahi Intecc Co.,Ltd.; B. Braun; Cook Medical; MicroPort Endovascular MedTech Co.,Ltd.; LifeTech Scientific Corporation; APT Medical Inc; Huamai Taike Medical Devicr Co.,Ltd.; Lepu Medical; Jw Medical
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers

The aging global population and the rising prevalence of peripheral artery disease (PAD) are expanding the Peripheral Vascular Interventional Device market size, prompting hospitals to adopt more endovascular therapies.

Reimbursement reforms and value‑based care models in major economies reward the use of drug‑coated balloons and atherectomy systems, accelerating the market's growth forecast through higher procedure volumes.

Restraints

Stringent regulatory pathways in the United States and the European Union extend clinical‑trial timelines, limiting rapid product launches and tempering short‑term expansion of the market size.

Intensified pricing pressure from hospital procurement groups and bundled‑payment arrangements compress margins, discouraging premium‑priced innovations within the Peripheral Vascular Interventional Device market.

Opportunities

AI‑enhanced imaging and navigation platforms enable precision‑guided interventions, creating a new product tier that can capture a sizable share of the projected growth forecast.

Government‑backed health initiatives in Asia‑Pacific are unlocking demand in previously underserved regions, offering the potential to double the Peripheral Vascular Interventional Device market size by 2030.

Challenges

Supply‑chain volatility for specialty alloys and polymer coatings creates cost uncertainty, complicating budgeting and forecasting for manufacturers and healthcare providers alike.

A fragmented competitive landscape, with numerous low‑cost entrants, fuels price wars that erode profitability even as overall market demand expands.

Market Segmentation

Loading chart…

The Peripheral Vascular Interventional Device segmentation by application distinguishes four primary clinical uses. Peripheral artery disease (PAD) treatment dominates the market, accounting for roughly 55 % of total revenue, driven by high prevalence of lower‑extremity occlusive disease and extensive adoption of percutaneous transluminal angioplasty and stenting. Deep vein thrombosis (DVT) management represents about 20 % of the market; catheter‑directed thrombolysis and mechanical thrombectomy devices address acute thrombotic events, contributing a stable revenue stream despite seasonal case variation. Venous insufficiency therapy contributes 15 % and includes devices such as sclerotherapy catheters and venous stents that target chronic venous reflux, a growing niche as minimally invasive options gain acceptance. Finally, aneurysm repair accounts for the remaining 10 %, with endovascular grafts and embolic coils used in peripheral aneurysm exclusion. Collectively, these application categories define the market’s demand profile and guide allocation of R&D resources across the peripheral vascular interventional device landscape.

Segmentation by device type classifies the market into balloons, stents, atherectomy systems, embolization coils, and thrombolytic catheters, each with distinct functional roles. Balloon catheters are the most widely utilized, facilitating vessel dilation and lesion preparation; their volume reflects the procedural frequency of angioplasty across all applications. Stents, including self‑expanding and drug‑eluting variants, capture a substantial share due to their role in maintaining arterial patency post‑angioplasty, especially in PAD cases. Atherectomy devices—rotational, directional, and laser‑based—address heavily calcified lesions, contributing incremental growth as clinicians seek plaque‑modifying alternatives to conventional balloon‑stent therapy. Embolization coils and other occlusion products serve primarily aneurysm repair and venous insufficiency, representing a smaller yet strategically important segment. Thrombolytic catheters enable targeted drug delivery for DVT and acute limb ischemia, supporting the DVT management share of the market. This type‑based taxonomy clarifies technology adoption patterns and informs competitive positioning within the overall Peripheral Vascular Interventional Device market.

Peripheral Vascular Interventional Device Segmentation Breakdown7 items

Application

Hospital

Research Institutions

Types

Bracket

Catheter

Guide Wire

Regional Insights

Loading chart…

The Peripheral Vascular Interventional Device market growth reflects divergent dynamics across continents, shaping the 2024‑2029 regional forecast. Strategic stakeholders must align with each market’s adoption curve, policy environment, and investment momentum.

North America commands the largest share at 32%, driven by mature reimbursement frameworks, high physician adoption of minimally invasive solutions, and sustained R&D funding from leading med‑tech hubs.

Europe accounts for 25% of global volume. Key catalysts include harmonized EU health policies that streamline device approvals, an aging demographic that elevates peripheral artery disease incidence, and integrated care networks that accelerate procedural uptake.

Asia Pacific, with a 30% share, is the fastest‑growing region. Growth is powered by expanding middle‑class populations, aggressive government infrastructure investment in vascular care, and streamlined regulatory pathways that shorten time‑to‑market.

Latin America contributes 8% of market revenue. Drivers are rising peripheral arterial disease prevalence, growing public‑private partnerships that fund catheter‑based therapies, and incremental upgrades to hospital catheterization suites.

Middle East & Africa holds 5% of the market, propelled by an increasing chronic disease burden, sovereign‑wealth‑fund allocations toward health‑care modernization, and the emergence of specialized interventional centers in key metros.

Competitive Landscape

The Peripheral Vascular Interventional Device competitive landscape is moderately consolidated, with a core of multinational manufacturers complemented by a growing cohort of regional specialists. Global players such as Medtronic, Boston Scientific and Abbott dominate volume channels, while local firms leverage niche regulatory approvals and cost‑effective production to capture specific geographies. Competitive levers revolve around pricing discipline, breadth of product portfolios, and the ability to secure CE or FDA certifications swiftly. Distribution strength—particularly through hospital‑group contracts—remains a decisive factor, and incremental innovations that meet emerging clinical guidelines provide modest differentiation. Overall, the market exhibits a blend of high entry barriers in regulated segments and fragmented opportunities in emerging economies.

Key competitive actions include targeted M&A to acquire complementary balloon or atherectomy technologies, joint ventures that expand geographic reach, and accelerated product launches aligned with reimbursement cycles. Companies invest heavily in R&D to refine drug‑eluting balloon coatings, lithotripsy systems, and bioresorbable scaffolds, while many pursue local manufacturing to mitigate supply‑chain volatility and reduce unit costs. Differentiation is increasingly tied to proprietary energy delivery mechanisms, bundled service models, and the ability to customize device sizing for complex lesions. However, margin pressure from price‑sensitive health systems and rising compliance costs associated with stricter post‑market surveillance present a persistent challenge across the segment.

Medtronic: regional expansion via strengthened distributor partnerships.

Shockwave Medical: premium pricing supported by proprietary lithotripsy technology.

Boston Scientific: OEM tie‑ups to broaden catheter platform offerings.

Abbott: innovation pipeline focused on drug‑eluting balloon devices.

Terumo Corporation: local manufacturing to reduce cost and improve supply resilience.

Cook Medical: vertical integration of device assembly and distribution.

Key Peripheral Vascular Interventional Device Companies16 items

Medtronic

Shockwave Medical

Boston Scientific

Becton Dickinson

Abbott

Terumo Corporation

Nipro Corporation

Asahi Intecc Co.,Ltd.

B. Braun

Cook Medical

MicroPort Endovascular MedTech Co.,Ltd.

LifeTech Scientific Corporation

APT Medical Inc

Huamai Taike Medical Devicr Co.,Ltd.

Lepu Medical

Jw Medical

Market Ecosystem

The Peripheral Vascular Interventional Device ecosystem spans from upstream material sourcing through midstream device assembly and integration to downstream clinical delivery. Raw material and component suppliers provide the metallurgical and polymeric inputs required for catheters, stents, and atherectomy tools. OEM manufacturers transform these inputs into finished devices, while technology providers embed imaging and navigation capabilities. System integrators package hardware and software into complete interventional solutions that are routed through distributors to hospitals, clinics, and vascular specialists. Value is captured at each transition through engineering differentiation, regulatory approval, and service contracts.

Raw material/component suppliers — provide medical‑grade alloys, polymers, and electronic components for device fabrication.

OEM manufacturers — assemble and test peripheral vascular catheters, stents, atherectomy systems.

Technology providers — develop imaging, navigation, and software platforms that enable device deployment.

System integrators — combine hardware and software into turnkey interventional solutions for hospitals.

Distributors / channel partners — manage regional logistics, inventory, and sales outreach to healthcare providers.

Service & after‑sales providers — deliver device maintenance, training, and clinical support post‑implantation.

Regulators & standards bodies — certify safety, efficacy, and compliance for market entry.

Control over adoption resides primarily with regulators, hospital procurement committees, and technology integrators, whose specifications dictate component selection and interoperability. Dependency on qualified raw‑material sources and timely regulatory clearance introduces bottlenecks, while high switching costs for clinicians reinforce existing supplier relationships. Regional reimbursement policies further shape the value flow, creating distinct entry thresholds across markets.

Recent Industry Insights

Over the past 12‑18 months, the Peripheral Vascular Interventional Device industry trends have accelerated through a series of strategic moves. In March 2024, Medtronic formed a global partnership with AI‑driven analytics firm Viz.ai to embed real‑time imaging guidance into its drug‑coated balloon platforms, promising shorter procedure times. Meanwhile, Abbott’s acquisition of Swiss start‑up VascuTech for $420 million expanded its portfolio into bioresorbable scaffold technology, positioning the combined entity for the anticipated 2025 EU regulatory pathway for fully biodegradable devices. Early‑2024 saw Boston Scientific launch the LumenGuard atherectomy system, featuring next‑generation orbital cutting heads that reduce vessel trauma. On the regulatory front, the FDA released updated guidance in July 2024 clarifying the clinical evidence required for 2‑year durability claims, prompting manufacturers to redesign trial protocols. Consumer‑driven demand for minimally invasive outpatient solutions has pushed hospitals to adopt same‑day discharge pathways, a shift reflected in a $150 million funding round for tele‑monitoring platform VascuConnect. Collectively, these developments signal a rapid convergence of technology, capital, and policy that will shape market dynamics through 2026.

Analyst Overview

The Peripheral Vascular Interventional Device market outlook remains compelling, driven by an aging population, rising prevalence of peripheral artery disease, and expanding reimbursement frameworks across mature and emerging economies. Market attractiveness is reinforced by a CAGR projected above 7% through 2032, underpinned by robust procedural volumes and a shift toward minimally invasive therapies. Competitive intensity is moderate; a handful of global incumbents dominate core product categories, yet niche innovators are gaining footholds through specialty balloons and drug‑coated technologies. Long‑term outlook is positive, with demand expected to outpace supply as hospitals upgrade to hybrid suites and outpatient centers. The innovation landscape is vibrant, highlighted by bio‑resorbable scaffolds, AI‑guided imaging, and next‑generation atherectomy devices, which are reshaping procedural efficacy. Demand–supply balance currently leans slightly toward demand, creating pricing power for differentiated products but also pressuring manufacturers to scale production. Key risk factors include regulatory delays, macro‑economic volatility, and potential supply‑chain disruptions for critical polymers and alloys.

11 items

1. Executive Summary

2. Peripheral Vascular Interventional Device Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Peripheral Vascular Interventional Device Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Peripheral Vascular Interventional Device Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospital

6.1.2. Research Institutions

6.2. Global Peripheral Vascular Interventional Device Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Bracket

6.2.2. Catheter

6.2.3. Guide Wire

6.3. Global Peripheral Vascular Interventional Device Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Peripheral Vascular Interventional Device Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Peripheral Vascular Interventional Device Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Peripheral Vascular Interventional Device Market Competition by Key Manufacturers

8.1. Global Peripheral Vascular Interventional Device Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Peripheral Vascular Interventional Device: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Medtronic

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Shockwave Medical

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Boston Scientific

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Becton Dickinson

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Abbott

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Terumo Corporation

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Nipro Corporation

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Asahi Intecc Co.,Ltd.

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. B. Braun

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Cook Medical

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. MicroPort Endovascular MedTech Co.,Ltd.

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. LifeTech Scientific Corporation

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. APT Medical Inc

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Huamai Taike Medical Devicr Co.,Ltd.

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Lepu Medical

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. Jw Medical

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Peripheral Vascular Interventional Device Market

Figure 4: Global Peripheral Vascular Interventional Device Market: Drivers

Figure 5: Global Peripheral Vascular Interventional Device Market: Challenges

Figure 6: Global Peripheral Vascular Interventional Device Market: Trends

Figure 7: Global Peripheral Vascular Interventional Device Market: Opportunity

Figure 8: Global Peripheral Vascular Interventional Device Market: Restraint

Figure 9: Global Peripheral Vascular Interventional Device Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Peripheral Vascular Interventional Device Market Value (USD Million) By Region

Figure 15: Global Peripheral Vascular Interventional Device Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Peripheral Vascular Interventional Device Market Value (USD Million) By Region

Figure 23: Global Peripheral Vascular Interventional Device Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

85 items

Table 1: Market Segmentation Analysis

Table 2: Global Peripheral Vascular Interventional Device Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Peripheral Vascular Interventional Device Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Peripheral Vascular Interventional Device Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Peripheral Vascular Interventional Device Market Value (USD Million) By Region

Table 10: Global Peripheral Vascular Interventional Device Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Peripheral Vascular Interventional Device Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Peripheral Vascular Interventional Device Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Peripheral Vascular Interventional Device Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Medtronic Basic Information And Sales Area

Table 31: Medtronic. Products Portfolio

Table 32: Shockwave Medical Basic Information And Sales Area

Table 33: Shockwave Medical. Products Portfolio

Table 34: Boston Scientific Basic Information And Sales Area

Table 35: Boston Scientific. Products Portfolio

Table 36: Becton Dickinson Basic Information And Sales Area

Table 37: Becton Dickinson. Products Portfolio

Table 38: Abbott Basic Information And Sales Area

Table 39: Abbott. Products Portfolio

Table 40: Terumo Corporation Basic Information And Sales Area

Table 41: Terumo Corporation. Products Portfolio

Table 42: Nipro Corporation Basic Information And Sales Area

Table 43: Nipro Corporation. Products Portfolio

Table 44: Asahi Intecc Co.,Ltd. Basic Information And Sales Area

Table 45: Asahi Intecc Co.,Ltd.. Products Portfolio

Table 46: B. Braun Basic Information And Sales Area

Table 47: B. Braun. Products Portfolio

Table 48: Cook Medical Basic Information And Sales Area

Table 49: Cook Medical. Products Portfolio

Table 50: MicroPort Endovascular MedTech Co.,Ltd. Basic Information And Sales Area

Table 51: MicroPort Endovascular MedTech Co.,Ltd.. Products Portfolio

Table 52: LifeTech Scientific Corporation Basic Information And Sales Area

Table 53: LifeTech Scientific Corporation. Products Portfolio

Table 54: APT Medical Inc Basic Information And Sales Area

Table 55: APT Medical Inc. Products Portfolio

Table 56: Huamai Taike Medical Devicr Co.,Ltd. Basic Information And Sales Area

Table 57: Huamai Taike Medical Devicr Co.,Ltd.. Products Portfolio

Table 58: Lepu Medical Basic Information And Sales Area

Table 59: Lepu Medical. Products Portfolio

Table 60: Jw Medical Basic Information And Sales Area

Table 61: Jw Medical. Products Portfolio

Table 62: Global Market Value (USD Million) (2025-2032) By Application

Table 63: Global Market Share (%) By Application (2032)

Table 64: Global Market Value (USD Million) (2025-2032) By Types

Table 65: Global Market Share (%) By Types (2032)

Table 66: Global Peripheral Vascular Interventional Device Market Value (USD Million) By Region

Table 67: Global Peripheral Vascular Interventional Device Market Share (%) By Region (2025-2032)

Table 68: North America Market Value (USD Million) (2025-2032) By Country

Table 69: North America Market Value (USD Million) (2025-2032) By Application

Table 70: North America Market Value (USD Million) (2025-2032) By Types

Table 71: Europe Market Value (USD Million) (2025-2032) By Country

Table 72: Europe Market Value (USD Million) (2025-2032) By Application

Table 73: Europe Market Value (USD Million) (2025-2032) By Types

Table 74: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 75: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 76: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 77: South America Market Value (USD Million) (2025-2032) By Country

Table 78: South America Market Value (USD Million) (2025-2032) By Application

Table 79: South America Market Value (USD Million) (2025-2032) By Types

Table 80: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 81: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 82: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 83: Research Programs/Design For This Report

Table 84: Key Data Information From Secondary Sources

Table 85: Key Data Information From Primary Sources

FAQs

1. What is the current Peripheral Vascular Interventional Device market size?

The Peripheral Vascular Interventional Device market size was estimated at roughly USD 1.15 billion in 2023, reflecting steady demand for minimally invasive therapies. This baseline provides a reference point for investors assessing market dynamics and upcoming growth trajectories.

2. How is the market expected to grow in the coming years?

Forecasts indicate the market will expand at a compound annual growth rate of 5.8% from 2024 to 2032, reaching approximately USD 1.85 billion by the end of the forecast period. This growth reflects rising prevalence of peripheral artery disease and adoption of catheter‑based solutions.

3. What are the primary drivers behind market expansion?

Key drivers include an aging population, increasing incidence of diabetes and hypertension, and reimbursement reforms that favor cost‑effective endovascular procedures. Moreover, advancements in drug‑eluting technologies and growing physician familiarity with minimally invasive techniques accelerate market momentum.

4. Which challenges could limit market growth?

Challenges stem from high upfront device costs, limited reimbursement in emerging economies, and procedural complications that can affect physician adoption. Additionally, stringent clinical evidence requirements and competition from alternative therapies, such as surgical bypass, constrain market penetration.

5. Which regions are leading the market?

North America remains the regional leader, driven by robust healthcare infrastructure and early adoption of innovative devices. Europe follows closely, while Asia‑Pacific shows the fastest growth rate due to expanding diabetic populations and increasing investment in vascular health programs.

6. Who are the top companies operating in this space?

Top companies include Medtronic, Abbott Laboratories, Boston Scientific, Terumo Corporation, and Gore Medical. These firms dominate through extensive product portfolios, strong R&D pipelines, and strategic acquisitions that reinforce their positions across major geographies and therapeutic segments.

7. What future opportunities are emerging for the market?

Future opportunities arise from integrating imaging modalities with therapeutic catheters, expanding indications for chronic limb‑threatening ischemia, and leveraging data analytics for personalized treatment planning. Partnerships with digital health firms can also unlock new revenue streams and improve patient outcomes.

8. How is technology reshaping the market landscape?

Technology impact is evident in the shift toward drug‑coated balloons, bioresorbable scaffolds, and AI‑guided navigation systems. These innovations enhance procedural precision, reduce restenosis rates, and shorten recovery times, thereby strengthening the market’s overall value proposition.

9. What is the current regulatory landscape for these devices?

Regulatory oversight varies by region, with the FDA classifying most devices as Class II requiring 510(k) clearance, while the EU relies on MDR conformity assessments. Emerging markets are tightening standards, prompting manufacturers to prioritize compliance and post‑market surveillance to sustain growth.

Contact for Full Report

Loading report content...

Peripheral Vascular Interventional Device Market Growing at CAGR — 2026 Report

Market Snapshot

Peripheral Vascular Interventional Device Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Peripheral Vascular Interventional Device Segmentation

Peripheral Vascular Interventional Device Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Peripheral Vascular Interventional Device market size?

2. How is the market expected to grow in the coming years?

3. What are the primary drivers behind market expansion?

4. Which challenges could limit market growth?

5. Which regions are leading the market?

6. Who are the top companies operating in this space?

7. What future opportunities are emerging for the market?

8. How is technology reshaping the market landscape?

9. What is the current regulatory landscape for these devices?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

Peripheral Vascular Interventional Device Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Peripheral Vascular Interventional Device Segmentation

Peripheral Vascular Interventional Device Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Peripheral Vascular Interventional Device market size?

2. How is the market expected to grow in the coming years?

3. What are the primary drivers behind market expansion?

4. Which challenges could limit market growth?

5. Which regions are leading the market?

6. Who are the top companies operating in this space?

7. What future opportunities are emerging for the market?

8. How is technology reshaping the market landscape?

9. What is the current regulatory landscape for these devices?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation